-
1
-
-
0037326161
-
The sodium/iodide symporter (NIS): Characterization, regulation, and medical significance
-
DOI 10.1210/er.2001-0029
-
O Dohán A De la Vieja V Paroder C Riedel M Artani M Reed, et al. 2003 The sodium/iodide symporter (NIS): characterization, regulation, and medical significance Endocr Rev 24 48 77 10.1210/er.2001-0029 12588808 (Pubitemid 36223279)
-
(2003)
Endocrine Reviews
, vol.24
, Issue.1
, pp. 48-77
-
-
Dohan, O.1
De La Vieja, A.2
Paroder, V.3
Riedel, C.4
Artani, M.5
Reed, M.6
Ginter, C.S.7
Carrasco, N.8
-
2
-
-
26244454529
-
Modulation of thyroid-specific gene expression in normal and nodular human thyroid tissues from adults: An in vivo effect of thyrotropin
-
DOI 10.1210/jc.2005-0800
-
R Bruno E Ferretti E Tosi F Arturi P Giannasio T Mattei, et al. 2005 Modulation of thyroid-specific gene expression in normal and nodular human thyroid tissues from adults: an in vivo effect of thyrotropin J Clin Endocrinol Metab 90 5692 5697 1:CAS:528:DC%2BD2MXhtFWjt7rP 10.1210/jc.2005-0800 16076943 (Pubitemid 41415477)
-
(2005)
Journal of Clinical Endocrinology and Metabolism
, vol.90
, Issue.10
, pp. 5692-5697
-
-
Bruno, R.1
Ferretti, E.2
Tosi, E.3
Arturi, F.4
Giannasio, P.5
Mattei, T.6
Scipioni, A.7
Presta, I.8
Morisi, R.9
Gulino, A.10
Filetti, S.11
Russo, D.12
-
3
-
-
33847190355
-
Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patients
-
1:CAS:528:DC%2BD2sXjt1Smu70%3D 10.1038/ncpendmet0449 17315034
-
M Schlumberger L Lacroix D Russo S Filetti JM Bidart 2007 Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patients Nat Clin Pract Endocrinol Metab 3 260 269 1:CAS:528:DC%2BD2sXjt1Smu70%3D 10.1038/ncpendmet0449 17315034
-
(2007)
Nat Clin Pract Endocrinol Metab
, vol.3
, pp. 260-269
-
-
Schlumberger, M.1
Lacroix, L.2
Russo, D.3
Filetti, S.4
Bidart, J.M.5
-
4
-
-
27944469859
-
Thyroid hormone withdrawal in patients with differentiated thyroid carcinoma: A one hundred thirty-patient pilot survey on consequences of hypothyroidism and a pharmacoeconomic comparison to recombinant thyrotropin administration
-
DOI 10.1089/thy.2005.15.1147
-
M Luster R Felbinger M Dietlein C Reiners 2005 Thyroid hormone withdrawal in patients with differentiated thyroid carcinoma: a one hundred thirty-patient pilot survey on consequences of hypothyroidism and a pharmacoeconomic comparison to recombinant thyrotropin administration Thyroid 15 1147 1155 1:CAS:528:DC%2BD2MXhtF2isLrN 10.1089/thy.2005.15.1147 16279848 (Pubitemid 41720721)
-
(2005)
Thyroid
, vol.15
, Issue.10
, pp. 1147-1155
-
-
Luster, M.1
Felbinger, R.2
Dietlein, M.3
Reiners, C.4
-
5
-
-
33644824080
-
A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal
-
DOI 10.1210/jc.2005-2064
-
PR Schroeder BR Haugen F Pacini C Reiners M Schlumberger SI Sherman, et al. 2006 A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal J Clin Endocrinol Metab 91 878 884 1:CAS:528:DC%2BD28Xis1Cmt70%3D 10.1210/jc.2005-2064 16394083 (Pubitemid 43357753)
-
(2006)
Journal of Clinical Endocrinology and Metabolism
, vol.91
, Issue.3
, pp. 878-884
-
-
Schroeder, P.R.1
Haugen, B.R.2
Pacini, F.3
Reiners, C.4
Schlumberger, M.5
Sherman, S.I.6
Cooper, D.S.7
Schuff, K.G.8
Braverman, L.E.9
Skarulis, M.C.10
Davies, T.F.11
Mazzaferri, E.L.12
Daniels, G.H.13
Ross, D.S.14
Luster, M.15
Samuels, M.H.16
Weintraub, B.D.17
Ridgway, E.C.18
Ladenson, P.W.19
-
6
-
-
34248998448
-
Sick leave for follow-up control in thyroid cancer patients: Comparison between stimulation with Thyrogen and thyroid hormone withdrawal
-
DOI 10.1530/EJE-06-0724
-
I Borget C Corone M Nocaudie M Allyn S Iacobelli M Schlumberger, et al. 2007 Sick leave for follow-up control in thyroid cancer patients: comparison between stimulation with Thyrogen and thyroid hormone withdrawal Eur J Endocrinol 156 531 538 1:CAS:528:DC%2BD2sXls1ynsLc%3D 10.1530/EJE-06-0724 17468188 (Pubitemid 46796519)
-
(2007)
European Journal of Endocrinology
, vol.156
, Issue.5
, pp. 531-538
-
-
Borget, I.1
Corone, C.2
Nocaudie, M.3
Allyn, M.4
Iacobelli, S.5
Schlumberger, M.6
De Pouvourville, G.7
-
7
-
-
66949116318
-
Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): A randomized controlled study
-
10.1111/j.1365-2265.2008.03424.x
-
D Taïeb F Sebag M Cherenko K Baumstarck-Barrau C Fortanier B Farman-Ara, et al. 2009 Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study Clin Endocrinol (Oxf) 71 115 123 10.1111/j.1365-2265.2008.03424.x
-
(2009)
Clin Endocrinol (Oxf)
, vol.71
, pp. 115-123
-
-
Taïeb, D.1
Sebag, F.2
Cherenko, M.3
Baumstarck-Barrau, K.4
Fortanier, C.5
Farman-Ara, B.6
-
8
-
-
33847720753
-
Short-term hypothyroidism after levothyroxine-withdrawal in patients with differentiated thyroid cancer: Clinical and quality of life consequences
-
DOI 10.1530/eje.1.02310
-
LH Duntas B Biondi 2007 Short-term hypothyroidism after Levothyroxine-withdrawal in patients with differentiated thyroid cancer: clinical and quality of life consequences Eur J Endocrinol 156 13 19 1:CAS:528:DC%2BD2sXntlyqtb4%3D 10.1530/eje.1.02310 17218721 (Pubitemid 46553899)
-
(2007)
European Journal of Endocrinology
, vol.156
, Issue.1
, pp. 13-19
-
-
Duntas, L.H.1
Biondi, B.2
-
9
-
-
0033341953
-
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer
-
1:CAS:528:DyaK1MXntlOqt74%3D 10.1210/jc.84.11.3877 10566623
-
BR Haugen F Pacini C Reiners M Schlumberger PW Ladenson SI Sherman, et al. 1999 A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer J Clin Endocrinol Metab 84 3877 3885 1:CAS:528:DyaK1MXntlOqt74%3D 10.1210/jc.84.11.3877 10566623
-
(1999)
J Clin Endocrinol Metab
, vol.84
, pp. 3877-3885
-
-
Haugen, B.R.1
Pacini, F.2
Reiners, C.3
Schlumberger, M.4
Ladenson, P.W.5
Sherman, S.I.6
-
10
-
-
33644816884
-
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: Results of an international, randomized, controlled study
-
DOI 10.1210/jc.2005-1651
-
F Pacini PW Ladenson M Schlumberger A Driedger M Luster RT Kloos, et al. 2006 Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study J Clin Endocrinol Metab 91 926 932 1:CAS:528:DC%2BD28Xis1CmtL8%3D 10.1210/jc.2005-1651 16384850 (Pubitemid 43357760)
-
(2006)
Journal of Clinical Endocrinology and Metabolism
, vol.91
, Issue.3
, pp. 926-932
-
-
Pacini, F.1
Ladenson, P.W.2
Schlumberger, M.3
Driedger, A.4
Luster, M.5
Kloos, R.T.6
Sherman, S.7
Haugen, B.8
Corone, C.9
Molinaro, E.10
Elisei, R.11
Ceccarelli, C.12
Pinchera, A.13
Wahl, R.L.14
Leboulleux, S.15
Ricard, M.16
Yoo, J.17
Busaidy, N.L.18
Delpassand, E.19
Hanscheid, H.20
Felbinger, R.21
Lassmann, M.22
Reiners, C.23
more..
-
11
-
-
16444375322
-
rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: A comprehensive review
-
DOI 10.1677/erc.1.00830
-
M Luster F Lippi B Jarzab P Perros M Lassmann C Reiners, et al. 2005 rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review Endocr Relat Cancer 12 49 64 1:CAS:528:DC%2BD2MXjsV2lsLg%3D 10.1677/erc.1.00830 15788638 (Pubitemid 40477087)
-
(2005)
Endocrine-Related Cancer
, vol.12
, Issue.1
, pp. 49-64
-
-
Luster, M.1
Lippi, F.2
Jarzab, B.3
Perros, P.4
Lassmann, M.5
Reiners, C.6
Pacini, F.7
-
12
-
-
33845233817
-
Recombinant human thyrotropin-assisted radioiodine therapy for patients with metastatic thyroid cancer who could not elevate endogenous thyrotropin or be withdrawn from thyroxine
-
DOI 10.1089/thy.2006.16.1121
-
RJ Robbins A Driedger J Magner U.S. and Canadian Thyrogen Compassionate Use Program Investigator Group 2006 Recombinant human thyrotropin-assisted radioiodine therapy for patients with metastatic thyroid cancer who could not elevate endogenous thyrotropin or be withdrawn from thyroxine Thyroid 16 1121 1130 1:CAS:528:DC%2BD28Xht1CgtbvI 10.1089/thy.2006.16.1121 17123339 (Pubitemid 44864487)
-
(2006)
Thyroid
, vol.16
, Issue.11
, pp. 1121-1130
-
-
Robbins, R.J.1
Driedger, A.2
Magner, J.3
-
13
-
-
0034328026
-
Compassionate use of recombinant human thyrotropin to facilitate radioiodine therapy: Case report and review of literature
-
1:STN:280:DC%2BD3M7gvVKgsg%3D%3D 11155220
-
RJ Robbins E Voelker W Wang HA Macapinlac SM Larson 2000 Compassionate use of recombinant human thyrotropin to facilitate radioiodine therapy: case report and review of literature Endocr Pract 6 460 464 1:STN:280: DC%2BD3M7gvVKgsg%3D%3D 11155220
-
(2000)
Endocr Pract
, vol.6
, pp. 460-464
-
-
Robbins, R.J.1
Voelker, E.2
Wang, W.3
MacApinlac, H.A.4
Larson, S.M.5
-
15
-
-
34250320635
-
Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases
-
1:CAS:528:DC%2BD2sXksFKgsQ%3D%3D 17138741
-
H Song B He A Prideaux Y Du E Frey W Kasecamp, et al. 2006 Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases J Nucl Med 47 1985 1994 1:CAS:528:DC%2BD2sXksFKgsQ%3D%3D 17138741
-
(2006)
J Nucl Med
, vol.47
, pp. 1985-1994
-
-
Song, H.1
He, B.2
Prideaux, A.3
Du, Y.4
Frey, E.5
Kasecamp, W.6
-
16
-
-
0038207951
-
Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapy
-
10.1007/s00259-002-1076-y 12634964
-
B de Keizer B Brans A Hoekstra PM Zelissen HP Koppeschaar CJ Lips, et al. 2003 Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapy Eur J Nucl Med Mol Imaging 30 367 373 10.1007/s00259-002-1076-y 12634964
-
(2003)
Eur J Nucl Med Mol Imaging
, vol.30
, pp. 367-373
-
-
De Keizer, B.1
Brans, B.2
Hoekstra, A.3
Zelissen, P.M.4
Koppeschaar, H.P.5
Lips, C.J.6
-
17
-
-
33748794776
-
Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patients
-
DOI 10.1111/j.1365-2265.2006.02626.x
-
C Pötzi A Moameni G Karanikas J Preitfellner A Becherer C Pirich, et al. 2006 Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patients Clin Endocrinol (Oxf) 65 519 523 10.1111/j.1365-2265.2006.02626. x (Pubitemid 44414277)
-
(2006)
Clinical Endocrinology
, vol.65
, Issue.4
, pp. 519-523
-
-
Potzi, C.1
Moameni, A.2
Karanikas, G.3
Preitfellner, J.4
Becherer, A.5
Pirich, C.6
Dudczak, R.7
-
18
-
-
0002727966
-
Iodine kinetics during I-131 scanning in patients with thyroid cancer: Comparison of studies with recombinant human TSH (rhTSH) vs. hypothyroidism [abstract 49]
-
S-G Park JC Reynolds F Brucker-Davis M Whatley K McEllin D Maxted, et al. 1996 Iodine kinetics during I-131 scanning in patients with thyroid cancer: comparison of studies with recombinant human TSH (rhTSH) vs. hypothyroidism [abstract 49] J Nucl Med 37 15P
-
(1996)
J Nucl Med
, vol.37
-
-
Park, S.-G.1
Reynolds, J.C.2
Brucker-Davis, F.3
Whatley, M.4
McEllin, K.5
Maxted, D.6
-
19
-
-
0030886175
-
Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma
-
DOI 10.1056/NEJM199709253371304
-
PW Ladenson LE Braverman EL Mazzaferri F Brucker-Davis DS Cooper JR Garber, et al. 1997 Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma N Engl J Med 337 888 896 1:CAS:528: DyaK2sXmtlylurY%3D 10.1056/NEJM199709253371304 9302303 (Pubitemid 27408571)
-
(1997)
New England Journal of Medicine
, vol.337
, Issue.13
, pp. 888-896
-
-
Ladenson, P.W.1
Braverman, L.E.2
Mazzaferri, E.L.3
Brucker-Davis, F.4
Cooper, D.S.5
Garber, J.R.6
Wondisford, F.E.7
Davies, T.F.8
Degroot, L.J.9
Daniels, G.H.10
Ross, D.S.11
Weintraub, B.D.12
Hay, I.D.13
Levis, S.14
Reynolds, J.C.15
Robbins, J.16
Becker, D.V.17
Cavalieri, R.R.18
Maxon, H.R.19
McEllin, K.20
Moscicki, R.21
more..
-
20
-
-
34548421107
-
124I-PET dosimetry in advanced differentiated thyroid cancer: Therapeutic impact
-
1:CAS:528:DC%2BD2sXhtFaht7rK 17690789
-
L Freudenberg W Jentzen R Görges T Petrich RJ Marlowe J Knust, et al. 2007 124I-PET dosimetry in advanced differentiated thyroid cancer: therapeutic impact Nuklearmedizin 46 121 128 1:CAS:528:DC%2BD2sXhtFaht7rK 17690789
-
(2007)
Nuklearmedizin
, vol.46
, pp. 121-128
-
-
Freudenberg, L.1
Jentzen, W.2
Görges, R.3
Petrich, T.4
Marlowe, R.J.5
Knust, J.6
-
21
-
-
0038360113
-
-
I. Fleming J.S. Cooper D.E. Henson R.V.P. Hutter B.J. Kennedy (eds). 5 Lippincott-Raven Philadelphia
-
Fleming I, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, editors. AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven; 1997.
-
(1997)
AJCC Cancer Staging Manual
-
-
-
22
-
-
34548388758
-
124I positron emission tomographic dosimetry and positron emission tomography/computed tomography imaging in differentiated thyroid cancer
-
H. Biersack F. Grunwald (eds). 2 Springer Berlin
-
Freudenberg L, Bockisch A, Jentzen W. 124I positron emission tomographic dosimetry and positron emission tomography/computed tomography imaging in differentiated thyroid cancer. In: Biersack H, Grunwald F, editors. Thyroid cancer. 2nd ed. Berlin: Springer; 2005.
-
(2005)
Thyroid Cancer
-
-
Freudenberg, L.1
Bockisch, A.2
Jentzen, W.3
-
24
-
-
0033622147
-
Preparation of 124I solutions after thermodistillation of irradiated 124TeO2 targets
-
1:CAS:528:DC%2BD3cXhtlCju7w%3D 10.1016/S0969-8043(99)00127-X 10697724
-
EJ Knust K Dutschka R Weinreich 2000 Preparation of 124I solutions after thermodistillation of irradiated 124TeO2 targets Appl Radiat Isot 52 181 184 1:CAS:528:DC%2BD3cXhtlCju7w%3D 10.1016/S0969-8043(99)00127-X 10697724
-
(2000)
Appl Radiat Isot
, vol.52
, pp. 181-184
-
-
Knust, E.J.1
Dutschka, K.2
Weinreich, R.3
-
27
-
-
0032899681
-
Thyroid cancer dosimetry using clearance fitting
-
1:STN:280:DyaK1M7jtFOltQ%3D%3D 9935068
-
EE Furhang SM Larson P Buranapong JL Humm 1999 Thyroid cancer dosimetry using clearance fitting J Nucl Med 40 131 136 1:STN:280:DyaK1M7jtFOltQ%3D%3D 9935068
-
(1999)
J Nucl Med
, vol.40
, pp. 131-136
-
-
Furhang, E.E.1
Larson, S.M.2
Buranapong, P.3
Humm, J.L.4
-
30
-
-
0347091259
-
Diagnostic value of high-resolution B-mode and power-mode sonography in the follow-up of thyroid cancer
-
DOI 10.1016/S0929-8266(02)00073-3, PII S0929826602000733
-
R Görges EG Eising D Fotescu K Renzing-Köhler A Frilling KW Schmid, et al. 2003 Diagnostic value of high-resolution B-mode and power-mode sonography in the follow-up of thyroid cancer Eur J Ultrasound 16 191 206 10.1016/S0929-8266(02)00073-3 12573788 (Pubitemid 36173575)
-
(2003)
European Journal of Ultrasound
, vol.16
, Issue.3
, pp. 191-206
-
-
Gorges, R.1
Eising, E.G.2
Fotescu, D.3
Renzing-Kohler, K.4
Frilling, A.5
Schmid, K.W.6
Bockisch, A.7
Dirsch, O.8
-
31
-
-
8344268520
-
124I-PET/CT in staging of patients with differentiated thyroid cancer
-
DOI 10.1007/s00330-004-2350-0
-
LS Freudenberg G Antoch W Jentzen R Pink J Knust R Görges, et al. 2004 Value of (124)I-PET/CT in staging of patients with differentiated thyroid cancer Eur Radiol 14 2092 2098 1:STN:280:DC%2BD2crjtVGmtw%3D%3D 10.1007/s00330-004-2350-0 15232708 (Pubitemid 39481183)
-
(2004)
European Radiology
, vol.14
, Issue.11
, pp. 2092-2098
-
-
Freudenberg, L.S.1
Antoch, G.2
Jentzen, W.3
Pink, R.4
Knust, J.5
Gorges, R.6
Muller, S.P.7
Bockisch, A.8
Debatin, J.F.9
Brandau, W.10
-
32
-
-
33747642244
-
Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy
-
DOI 10.1210/jc.2005-2838
-
C Durante N Haddy E Baudin S Leboulleux D Hartl JP Travagli, et al. 2006 Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy J Clin Endocrinol Metab 91 2892 2899 1:CAS:528:DC%2BD28XosFGhs70%3D 10.1210/jc.2005-2838 16684830 (Pubitemid 44271732)
-
(2006)
Journal of Clinical Endocrinology and Metabolism
, vol.91
, Issue.8
, pp. 2892-2899
-
-
Durante, C.1
Haddy, N.2
Baudin, E.3
Leboulleux, S.4
Hartl, D.5
Travagli, J.P.6
Caillou, B.7
Ricard, M.8
Lumbroso, J.D.9
De Vathaire, F.10
Schlumberger, M.11
-
33
-
-
70449373427
-
Area under the curve of TSH after levothyroxine withdrawal versus administration of recombinant human TSH (rhTSH): Possible implications for tumor growth
-
19893921
-
PW Rosário DS Salles S Purisch 2009 Area under the curve of TSH after levothyroxine withdrawal versus administration of recombinant human TSH (rhTSH): possible implications for tumor growth Arq Bras Endocrinol Metabol 53 767 770 19893921
-
(2009)
Arq Bras Endocrinol Metabol
, vol.53
, pp. 767-770
-
-
Rosário, P.W.1
Salles, D.S.2
Purisch, S.3
-
34
-
-
77954866328
-
Thyroid remnant dose: 124I-PET/CT dosimetric comparison of rhTSH versus thyroid hormone withholding before radioiodine remnant ablation in differentiated thyroid cancer
-
1:CAS:528:DC%2BC3cXhtVeisL%2FM 10.1055/s-0029-1225350 19856257
-
LS Freudenberg C Frömke T Petrich RJ Marlowe WW Koska W Brandau, et al. 2010 Thyroid remnant dose: 124I-PET/CT dosimetric comparison of rhTSH versus thyroid hormone withholding before radioiodine remnant ablation in differentiated thyroid cancer Exp Clin Endocrinol Diabetes 118 393 399 1:CAS:528:DC%2BC3cXhtVeisL%2FM 10.1055/s-0029-1225350 19856257
-
(2010)
Exp Clin Endocrinol Diabetes
, vol.118
, pp. 393-399
-
-
Freudenberg, L.S.1
Frömke, C.2
Petrich, T.3
Marlowe, R.J.4
Koska, W.W.5
Brandau, W.6
-
35
-
-
0036841049
-
A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation
-
1:CAS:528:DC%2BD38XptV2mt7k%3D 12411552
-
RJ Robbins SM Larson N Sinha A Shaha C Divgi KS Pentlow, et al. 2002 A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation J Nucl Med 43 1482 1488 1:CAS:528:DC%2BD38XptV2mt7k%3D 12411552
-
(2002)
J Nucl Med
, vol.43
, pp. 1482-1488
-
-
Robbins, R.J.1
Larson, S.M.2
Sinha, N.3
Shaha, A.4
Divgi, C.5
Pentlow, K.S.6
-
36
-
-
33748114927
-
Recombinant human thyroid-stimulating hormone is effective for radioiodine ablation of post-surgical thyroid remnants
-
DOI 10.1097/00006231-200608000-00005, PII 0000623120060800000005
-
D Barbaro G Boni G Meucci U Simi P Lapi P Orsini, et al. 2006 Recombinant human thyroid-stimulating hormone is effective for radioiodine ablation of post-surgical thyroid remnants Nucl Med Commun 27 627 632 1:CAS:528: DC%2BD28Xms1ykt7k%3D 10.1097/00006231-200608000-00005 16829763 (Pubitemid 44305303)
-
(2006)
Nuclear Medicine Communications
, vol.27
, Issue.8
, pp. 627-632
-
-
Barbaro, D.1
Boni, G.2
Meucci, G.3
Simi, U.4
Lapi, P.5
Orsini, P.6
Pasquini, C.7
Turco, A.8
Mariani, G.9
-
37
-
-
57349134887
-
Preparation with recombinant human thyroid-stimulating hormone for thyroid remnant ablation with 131I is associated with lowered radiotoxicity
-
10.2967/jnumed.108.050591 18927337
-
PW Rosário MA Borges S Purisch 2008 Preparation with recombinant human thyroid-stimulating hormone for thyroid remnant ablation with 131I is associated with lowered radiotoxicity J Nucl Med 49 1776 1782 10.2967/jnumed.108.050591 18927337
-
(2008)
J Nucl Med
, vol.49
, pp. 1776-1782
-
-
Rosário, P.W.1
Borges, M.A.2
Purisch, S.3
-
38
-
-
44149083802
-
Recombinant human TSH-assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone withdrawal
-
DOI 10.2967/jnumed.107.049072
-
RM Tuttle M Brokhin G Omry AJ Martorella SM Larson RK Grewal, et al. 2008 Recombinant human TSH-assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone withdrawal J Nucl Med 49 764 770 10.2967/jnumed.107.049072 18413378 (Pubitemid 351717542)
-
(2008)
Journal of Nuclear Medicine
, vol.49
, Issue.5
, pp. 764-770
-
-
Tuttle, R.M.1
Brokhin, M.2
Omry, G.3
Martorella, A.J.4
Larson, S.M.5
Grewal, R.K.6
Fleisher, M.7
Robbins, R.J.8
-
39
-
-
62649094564
-
Low-activity (2.0 GBq; 54 mCi) radioiodine post-surgical remnant ablation in thyroid cancer: Comparison between hormone withdrawal and use of rhTSH in low-risk patients
-
1:CAS:528:DC%2BD1MXhsVOhsbvK 10.1530/EJE-08-0669 19074463
-
M Chianelli V Todino FM Graziano C Panunzi D Pace R Guglielmi, et al. 2009 Low-activity (2.0 GBq; 54 mCi) radioiodine post-surgical remnant ablation in thyroid cancer: comparison between hormone withdrawal and use of rhTSH in low-risk patients Eur J Endocrinol 160 431 436 1:CAS:528:DC%2BD1MXhsVOhsbvK 10.1530/EJE-08-0669 19074463
-
(2009)
Eur J Endocrinol
, vol.160
, pp. 431-436
-
-
Chianelli, M.1
Todino, V.2
Graziano, F.M.3
Panunzi, C.4
Pace, D.5
Guglielmi, R.6
-
40
-
-
0347134611
-
Iodine excretion during stimulation with rhTSH in differentiated thyroid carcinoma
-
14668956
-
M Löffler M Weckesser C Franzius P Kies O Schober 2003 Iodine excretion during stimulation with rhTSH in differentiated thyroid carcinoma Nuklearmedizin 42 240 243 14668956
-
(2003)
Nuklearmedizin
, vol.42
, pp. 240-243
-
-
Löffler, M.1
Weckesser, M.2
Franzius, C.3
Kies, P.4
Schober, O.5
-
41
-
-
0036271745
-
Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET
-
1:CAS:528:DC%2BD38XlvVWnu7k%3D 10.1007/s00259-002-0775-8 12029549
-
SM Eschmann G Reischl K Bilger J Kupferschläger MH Thelen BM Dohmen, et al. 2002 Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET Eur J Nucl Med Mol Imaging 29 760 767 1:CAS:528:DC%2BD38XlvVWnu7k%3D 10.1007/s00259-002-0775-8 12029549
-
(2002)
Eur J Nucl Med Mol Imaging
, vol.29
, pp. 760-767
-
-
Eschmann, S.M.1
Reischl, G.2
Bilger, K.3
Kupferschläger, J.4
Thelen, M.H.5
Dohmen, B.M.6
-
42
-
-
4544236386
-
Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software
-
1:CAS:528:DC%2BD2cXnsFSmu70%3D 15299063
-
G Sgouros KS Kolbert A Sheikh KS Pentlow EF Mun A Barth, et al. 2004 Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software J Nucl Med 45 1366 1372 1:CAS:528:DC%2BD2cXnsFSmu70%3D 15299063
-
(2004)
J Nucl Med
, vol.45
, pp. 1366-1372
-
-
Sgouros, G.1
Kolbert, K.S.2
Sheikh, A.3
Pentlow, K.S.4
Mun, E.F.5
Barth, A.6
|